Evelo Biosciences, Inc.

Evelo Biosciences, Inc. is a clinical-stage biotechnology company that focuses on the development of therapies for cancer and autoimmune diseases. They harness the power of the gut-body network, aiming to modulate the immune system safely and effectively. Evelo Biosciences utilizes their proprietary oral biologics platform to create therapies that act on specific cells in the gut, delivering therapeutic effects throughout the body. Through their innovative approach, they strive to improve patients' lives and create a new paradigm in medicine.